PharmaShots | Incisive News in 3 Shots

Subscribe Now

AlloVir

Kalaris Therapeutics Reverse Merges with AlloVir to Advance Therapies Focusing on Retinal Diseases

Kalaris Therapeutics Reverse Merges with AlloVir to Advance Therapies Focusing on Retinal Diseases

November 11, 2024

AlloVir’s Posoleucel Receives the US FDA’s RMAT Designation for Prevention of Multiple Infections from 6 Viruses in Patient with Allogeneic Hematopoietic Cell Transplant

AlloVir’s Posoleucel Receives the US FDA’s RMAT Designation for Prevention of Multiple Infections from 6 Viruses in Patient with A...

April 20, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us